Therapeutic Management of Vestibular Disorders During Pregnancy: A Narrative and Evidence-Based Review
Abstract
Vestibular disorders such as vestibular migraine (VM), benign paroxysmal positional vertigo (BPPV), Ménière's disease (MD), persistent postural-perceptual dizziness (PPPD), and vestibular neuritis (VN) are not uncommon among women of reproductive age and may occur or worsen during pregnancy. However, the management of these disorders during gestation is complicated by physiological changes, the limited safety data on many medications, and ethical constraints in clinical research involving pregnant individuals. This review focuses on the therapeutic strategies employed in managing vestibular disorders during pregnancy, highlighting pharmacological and non-pharmacological interventions, evidence-based approaches, current limitations, and areas requiring further research. Emphasis is placed on safety profiles, individualized care, and interdisciplinary collaboration to optimize maternal health while minimizing fetal risk.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.